Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
01 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/01/3108375/0/en/Inmagene-Doses-First-Patient-in-the-ADAPTIVE-Phase-2b-Trial-of-IMG-007-a-Nondepleting-Anti-OX40-mAb-with-an-Extended-Half-life-in-Patients-with-Moderate-to-Severe-Atopic-Dermatitis.html
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067491/0/en/Inmagene-Reports-Topline-Results-from-Phase-2a-Study-of-IMG-007-a-Nondepleting-Anti-OX40-Monoclonal-Antibody-with-an-Extended-Half-life-in-Patients-with-Alopecia-Areata.html
09 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/09/3007096/0/en/Inmagene-Reports-Positive-Topline-Results-of-IMG-007-a-Nondepleting-Anti-OX40-Monoclonal-Antibody-with-an-Extended-Half-Life-for-the-Treatment-of-Atopic-Dermatitis.html
23 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/23/3001242/0/en/Ikena-Oncology-and-Inmagene-Biopharmaceuticals-Announce-Agreement-for-Merger-and-Private-Placement.html
09 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//en/news-release/2024/10/09/2960551/0/en/Inmagene-to-Host-Virtual-KOL-Event-on-the-Inhibition-of-the-OX40-OX40L-Signaling-in-the-Treatment-of-Atopic-Dermatitis-and-Alopecia-Areata.html
27 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/27/2905260/0/en/Inmagene-Announces-Positive-Topline-Results-of-a-Multiple-Ascending-Dose-MAD-Study-of-IMG-004-a-Non-covalent-Reversible-BTK-Inhibitor-with-Once-Daily-Dosing-Potential.html
ABOUT THIS PAGE